Clinical Trials Logo
  1. Home
  2. Tattoo
  3. NCT02877667

Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol — SOL1601  

Tattoo Clinical Trial

Official title:
Soliton Planar Acoustic Wave Device System for Dermal Clearing Human Trial Protocol

Clinical Trial Summary

Study of new acoustic wave device as an accessory to laser treatment in tattoo reduction.

Clinical Trial Description

A non-significant risk, single center, prospective device trial to evaluate the number of passes of Q-Switch laser treatment that can be completed with a Q-Switch Laser alone compared to use of the Soliton Planar Acoustic Wave Device System (AWD) System as an accessory to Q-switched laser in tattoo reduction treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02877667
Study type Interventional
Source Soliton
Contact
Status Completed
Phase N/A
Start date July 2016
Completion date April 30, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT02372786 - 7% Lidocaine/7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream Phase 4
Completed NCT01624688 - Optimizing Tattoo Removal: a Side-by-side Comparison in the Search for One Treatment Tattoo Removal N/A
Not yet recruiting NCT00409162 - Safety and Efficacy Study of a New Device for Tattoo Removal N/A
Completed NCT05515146 - Lymphovascular Abnormalities Under Tattoos